232 related articles for article (PubMed ID: 15243307)
1. In vivo and in vitro characterization of the novel antiarrhythmic agent SSR149744C: electrophysiological, anti-adrenergic, and anti-angiotensin II effects.
Gautier P; Guillemare E; Djandjighian L; Marion A; Planchenault J; Bernhart C; Herbert JM; Nisato D
J Cardiovasc Pharmacol; 2004 Aug; 44(2):244-57. PubMed ID: 15243307
[TBL] [Abstract][Full Text] [Related]
2. In vivo and in vitro antiarrhythmic effects of SSR149744C in animal models of atrial fibrillation and ventricular arrhythmias.
Gautier P; Serre M; Cosnier-Pucheu S; Djandjighian L; Roccon A; Herbert JM; Nisato D
J Cardiovasc Pharmacol; 2005 Feb; 45(2):125-35. PubMed ID: 15654261
[TBL] [Abstract][Full Text] [Related]
3. Electrophysiologic characterization of dronedarone in guinea pig ventricular cells.
Gautier P; Guillemare E; Marion A; Bertrand JP; Tourneur Y; Nisato D
J Cardiovasc Pharmacol; 2003 Feb; 41(2):191-202. PubMed ID: 12548079
[TBL] [Abstract][Full Text] [Related]
4. Multiple cellular electrophysiological effects of a novel antiarrhythmic furoquinoline derivative HA-7 [N-benzyl-7-methoxy-2,3,4,9-tetrahydrofuro[2,3-b]quinoline-3,4-dione] in guinea pig cardiac preparations.
Chang GJ; Su MJ; Kuo SC; Lin TP; Lee YS
J Pharmacol Exp Ther; 2006 Jan; 316(1):380-91. PubMed ID: 16174797
[TBL] [Abstract][Full Text] [Related]
5. Effects of the novel amiodarone-like compound SAR114646A on cardiac ion channels and ventricular arrhythmias in rats.
Goegelein H; Gautier P; Roccon A; O'Connor S; Ruetten H
Naunyn Schmiedebergs Arch Pharmacol; 2011 Sep; 384(3):231-44. PubMed ID: 21766160
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo effects of the atrial selective antiarrhythmic compound AVE1231.
Wirth KJ; Brendel J; Steinmeyer K; Linz DK; Rütten H; Gögelein H
J Cardiovasc Pharmacol; 2007 Apr; 49(4):197-206. PubMed ID: 17438404
[TBL] [Abstract][Full Text] [Related]
7. Electrophysiologic properties of UK-66,914, a novel class III antiarrhythmic agent.
Gwilt M; Dalrymple HW; Burges RA; Blackburn KJ; Dickinson RP; Cross PE; Higgins AJ
J Cardiovasc Pharmacol; 1991 Mar; 17(3):376-85. PubMed ID: 1711597
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiological and mechanical effects of caffeic acid phenethyl ester, a novel cardioprotective agent with antiarrhythmic activity, in guinea-pig heart.
Chang GJ; Chang CJ; Chen WJ; Yeh YH; Lee HY
Eur J Pharmacol; 2013 Feb; 702(1-3):194-207. PubMed ID: 23396228
[TBL] [Abstract][Full Text] [Related]
9. Electrophysiological effects of Org 7797 in the closed-chest anaesthetized dog.
Leboeuf J; Basiez M; Massingham R
Br J Pharmacol; 1993 Sep; 110(1):23-8. PubMed ID: 8220882
[TBL] [Abstract][Full Text] [Related]
10. Electromechanical characterization of cinnamophilin, a natural thromboxane A2 receptor antagonist with anti-arrhythmic activity, in guinea-pig heart.
Chang GJ; Su MJ; Wu TS; Chen WP; Kuo CM
Br J Pharmacol; 2008 Jan; 153(1):110-23. PubMed ID: 17965733
[TBL] [Abstract][Full Text] [Related]
11. SD-3212, a new class I and IV antiarrhythmic drug: a potent inhibitor of the muscarinic acetylcholine-receptor-operated potassium current in guinea-pig atrial cells.
Hara Y; Nakaya H
Br J Pharmacol; 1995 Nov; 116(6):2750-6. PubMed ID: 8591000
[TBL] [Abstract][Full Text] [Related]
12. Cardiac electrophysiologic and antiarrhythmic actions of a pavine alkaloid derivative, O-methyl-neocaryachine, in rat heart.
Chang GJ; Su MJ; Hung LM; Lee SS
Br J Pharmacol; 2002 Jun; 136(3):459-71. PubMed ID: 12023949
[TBL] [Abstract][Full Text] [Related]
13. Investigation of electrophysiologic mechanisms for the antiarrhythmic actions of R 56865 in cardiac glycoside toxicity.
Damiano BP; Stump GL; Yagel SK
J Cardiovasc Pharmacol; 1991 Sep; 18(3):415-28. PubMed ID: 1720842
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and preliminary characterization of a novel antiarrhythmic compound (KB130015) with an improved toxicity profile compared with amiodarone.
Carlsson B; Singh BN; Temciuc M; Nilsson S; Li YL; Mellin C; Malm J
J Med Chem; 2002 Jan; 45(3):623-30. PubMed ID: 11806713
[TBL] [Abstract][Full Text] [Related]
15. Trapidil enhances the slowly activating delayed rectifier potassium current and suppresses the transient inward current induced by catecholamine in Guinea pig ventricular myocytes.
Marumoto A; Hasegawa J; Zhang F; Moritani H; Harada T; Sano A; Miura N; Kishimoto Y; Ohgi S
J Cardiovasc Pharmacol; 2005 Aug; 46(2):167-76. PubMed ID: 16044028
[TBL] [Abstract][Full Text] [Related]
16. [Antiarrhythmic effect of TJ0711].
Zhang XJ; Qiu J; Li G
Yao Xue Xue Bao; 2014 Mar; 49(3):419-26. PubMed ID: 24961117
[TBL] [Abstract][Full Text] [Related]
17. Sophoridine manifests as a leading compound for anti-arrhythmia with multiple ion-channel blocking effects.
Song T; Hao Y; Wang M; Li T; Zhao C; Li J; Hou Y
Phytomedicine; 2023 Apr; 112():154688. PubMed ID: 36738478
[TBL] [Abstract][Full Text] [Related]
18. Use-dependent effects of the class III antiarrhythmic agent NE-10064 (azimilide) on cardiac repolarization: block of delayed rectifier potassium and L-type calcium currents.
Fermini B; Jurkiewicz NK; Jow B; Guinosso PJ; Baskin EP; Lynch JJ; Salata JJ
J Cardiovasc Pharmacol; 1995 Aug; 26(2):259-71. PubMed ID: 7475051
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of G protein-coupled and ATP-sensitive potassium currents by 2-methyl-3-(3,5-diiodo-4-carboxymethoxybenzyl)benzofuran (KB130015), an amiodarone derivative.
Brandts B; Borchard R; Macianskiene R; Gendviliene V; Dirkmann D; Van Bracht M; Prull M; Meine M; Wickenbrock I; Mubagwa K; Trappe HJ
J Pharmacol Exp Ther; 2004 Jan; 308(1):134-42. PubMed ID: 14569071
[TBL] [Abstract][Full Text] [Related]
20. Electrophysiological mechanisms of sophocarpine as a potential antiarrhythmic agent.
Yang ZF; Li CZ; Wang W; Chen YM; Zhang Y; Liu YM; Wang HW
Acta Pharmacol Sin; 2011 Mar; 32(3):311-20. PubMed ID: 21258356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
